Literature DB >> 26825388

A Case of Signet Ring Cell Carcinoma of the Gallbladder Which Was Treated by Aggressive Surgery and Intensive Adjuvant Chemotherapy.

Masatsugu Hiraki1, Junji Ueda1, Keita Kai2, Takao Ide1, Masako Asai1, Takao Ohtsuka1, Naohiko Kohya1, Shinsuke Mukai3, Kenji Kitahara1, Hirokazu Noshiro4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 26825388     DOI： 10.1007/s12029-016-9804-x

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  18 in total

Review 1.  Primary signet ring cell carcinoma of gall bladder: report of an extremely rare histological type of primary gall bladder carcinoma.

Authors:  Zubair Ahmad; Asim Qureshi
Journal:  BMJ Case Rep       Date:  2010-09-07

2.  Signet ring cell carcinoma of the lower bile duct with rapid growth: report of a case.

Authors:  Masatsugu Hiraki; Hiroyuki Yakushiji; Kazuyoshi Hashiguchil; Sadami Harada; Keiichiro Okada; Yudai Goto; Hideo Ikeda; Daisuke Mori; Osamu Tokunaga; Kohji Miyazaki
Journal:  Hepatogastroenterology       Date:  2007 Oct-Nov

Review 3.  Carcinoma of the gallbladder.

Authors:  Sanjeev Misra; Arun Chaturvedi; Naresh C Misra; Indra D Sharma
Journal:  Lancet Oncol       Date:  2003-03       Impact factor: 41.316

4.  Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer.

Authors:  Takuji Okusaka; Hiroshi Ishii; Akihiro Funakoshi; Kenji Yamao; Shinichi Ohkawa; Soh Saito; Hiroshi Saito; Toshio Tsuyuguchi
Journal:  Cancer Chemother Pharmacol       Date:  2005-09-02       Impact factor: 3.333

5.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

6.  Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

Authors:  Jennifer J Knox; David Hedley; Amit Oza; Ron Feld; Lillian L Siu; Eric Chen; Mahsan Nematollahi; Gregory R Pond; Jessica Zhang; Malcolm J Moore
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

7.  S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study.

Authors:  Junji Furuse; Takuji Okusaka; Narikazu Boku; Shinichi Ohkawa; Akira Sawaki; Toshikazu Masumoto; Akihiro Funakoshi
Journal:  Cancer Chemother Pharmacol       Date:  2008-01-23       Impact factor: 3.333

8.  Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).

Authors:  Chigusa Morizane; Takuji Okusaka; Junki Mizusawa; Atsuo Takashima; Makoto Ueno; Masafumi Ikeda; Yasuo Hamamoto; Hiroshi Ishii; Narikazu Boku; Junji Furuse
Journal:  Cancer Sci       Date:  2013-07-25       Impact factor: 6.716

9.  Intestinal-type adenocarcinoma of the gallbladder. A clinicopathologic study of seven cases.

Authors:  J Albores-Saavedra; M Nadji; D E Henson
Journal:  Am J Surg Pathol       Date:  1986-01       Impact factor: 6.394

10.  Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma.

Authors:  Naohiko Kohya; Kohji Miyazaki
Journal:  J Surg Oncol       Date:  2008-05-01       Impact factor: 3.454
View more
  1 in total

1.  Mucinous carcinoma of the gallbladder with signet ring cells.

Authors:  Takeshi Fukuda; Yoshihiro Sakimoto; Kenichi Narita; Mitsuko Ariizumi; Yoshio Aizawa; Kunihiko Fukuda
Journal:  Radiol Case Rep       Date:  2017-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.